DePuy Synthes Products

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, DePuy Synthes Products sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 2 currently recruiting 1 completed upper quartile by trial count

DePuy Synthes Products: 3 sponsored US clinical trials, 2 recruiting.

DePuy Synthes Products sponsors 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Degenerative Spine Disease, with 1 trials.

Upper-quartile sponsor footprint

DePuy Synthes Products sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the DePuy Synthes Products pipeline

2 recruiting of 3 indexed (67% open); 1 completed (33%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Degenerative Spine Disease (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

DePuy Synthes Products: open-pipeline peers nationwide

Peers matched on 3 registered trials and 67% open enrollment, not the therapeutic-area sidebar.

DePuy Synthes Products sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 234567 0%20%40%60%80% Total trials Recruiting share DePuy Synthes Products10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAbbisko Therapeutics CoABL BioAccelerated Cure Project for Multiple SclerosisAdvanced Reconstructive Surgery Alliance
DePuy Synthes Products sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

DePuy Synthes Products sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 67% open enrollment (± trial volume)

What to do with this DePuy Synthes Products page

3 registered trials is a research-attention snapshot, not an endorsement of DePuy Synthes Products or any single study.

  • 2 of DePuy Synthes Products's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Degenerative Spine Disease is the condition DePuy Synthes Products studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Degenerative Spine Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

DePuy Synthes Products pipeline card: 3 registered trials from official public datasets.Report a data error.